Al-Gadi M, Hill S J
Br J Pharmacol. 1985 Aug;85(4):877-88. doi: 10.1111/j.1476-5381.1985.tb11087.x.
The characteristics of histamine-stimulated adenosine 3':5'-cyclic monophosphate (cyclic AMP) accumulation in slices of rabbit cerebral cortex have been investigated. The selective H2-receptor antagonists, cimetidine, tiotidine, metiamide and ranitidine appeared to antagonize the stimulation of cyclic AMP accumulation elicited by histamine in a competitive manner consistent with an interaction with histamine H2-receptors. The H1-receptor antagonist mepyramine (0.8 microM) produced only a weak inhibition of the response to histamine. The inhibition appeared to be non-competitive producing a decrease in the maximal response with little effect on the EC50 value. The specific H2-receptor agonist, impromidine, produced a maximum response of only 31 +/- 2% of that obtained with histamine. Studies with histamine and impromidine in combination indicated that impromidine was not acting as a partial agonist. 2-Thiazolylethylamine, a selective H1-agonist, produced only a weak response (EC50 approximately 1mM) yielding a relative potency with respect to histamine (= 100) of 2.5. In the presence of a supramaximal concentration of impromidine, histamine and 2-thiazolylethylamine further elevated the response to impromidine. In these conditions the relative potency of 2-thiazolylethylamine was increased to 59 (histamine = 100), a value which was comparable with that reported for H1-receptor-mediated contractions of guinea-pig ileum. The H1-receptor antagonists mepyramine, promethazine, triprolidine and chlorpheniramine competitively antagonized the potentiation of impromidine-stimulated cyclic AMP accumulation elicited by histamine and 2-thiazolylethylamine in rabbit cerebral cortex without affecting the response to impromidine alone. (+)-Chlorpheniramine was some 150 fold more potent than the (-)-isomer in this respect. Histamine and adenosine in combination had a much greater than additive effect on the accumulation of cyclic AMP in rabbit cerebral cortical slices. The potentiation of the adenosine response could be partially but not completely antagonized by either cimetidine or mepyramine. In the presence of H2-receptor blockade with 0.02 mM tiotidine, histamine elicited a significant potentiation (EC50 44 microM) of the response to adenosine. This response was antagonized competitively by mepyramine yielding a KB value of 0.05 microM similar to that obtained from inhibition of the potentiation of impromidine-stimulated accumulation of cyclic AMP (0.02 microM). These results suggest that there are two components in the response to histamine in rabbit cerebral cortical slices. The first component appears to be mediated by histamine H2-receptors while the second, mepyramine-sensitive, component has some ofthe characteristics ofan H,-receptor mediated response and requires prior stimulation of adenosine- or H2-receptors to produce its effect.
已对组胺刺激兔大脑皮层切片中3':5'-环磷酸腺苷(环磷腺苷)积累的特性进行了研究。选择性H2受体拮抗剂西咪替丁、替奥替丁、甲硫米特和雷尼替丁似乎以竞争性方式拮抗组胺引起的环磷腺苷积累的刺激,这与它们与组胺H2受体的相互作用一致。H1受体拮抗剂美吡拉敏(0.8微摩尔)对组胺反应仅产生微弱抑制。这种抑制似乎是非竞争性的,导致最大反应降低,而对半数有效浓度(EC50)值影响很小。特异性H2受体激动剂英普咪定产生的最大反应仅为组胺所获最大反应的31±2%。组胺与英普咪定联合研究表明,英普咪定并非作为部分激动剂起作用。2-噻唑基乙胺,一种选择性H1激动剂,仅产生微弱反应(EC50约1毫摩尔),相对于组胺(=100)的相对效价为2.5。在英普咪定超最大浓度存在下,组胺和2-噻唑基乙胺进一步提高了对英普咪定的反应。在这些条件下,2-噻唑基乙胺的相对效价增加到59(组胺=100),该值与豚鼠回肠H1受体介导的收缩所报道的值相当。H1受体拮抗剂美吡拉敏、异丙嗪、曲普利啶和氯苯那敏竞争性拮抗组胺和2-噻唑基乙胺在兔大脑皮层中引起的英普咪定刺激的环磷腺苷积累的增强,而不影响对单独英普咪定的反应。在这方面,(+)-氯苯那敏的效力比(-)-异构体大约强150倍。组胺和腺苷联合对兔大脑皮层切片中环磷腺苷的积累具有远大于相加的作用。腺苷反应的增强可被西咪替丁或美吡拉敏部分但非完全拮抗。在0.02毫摩尔替奥替丁阻断H2受体的情况下,组胺引起对腺苷反应的显著增强(EC50 44微摩尔)。美吡拉敏竞争性拮抗该反应,产生的平衡解离常数(KB)值为0.05微摩尔,与抑制英普咪定刺激的环磷腺苷积累增强(0.02微摩尔)所获得的值相似。这些结果表明,兔大脑皮层切片中对组胺的反应有两个成分。第一个成分似乎由组胺H2受体介导,而第二个对美吡拉敏敏感的成分具有一些H1受体介导反应的特征,并且需要预先刺激腺苷或H2受体才能产生其效应。